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Abstract
Nicotine exposure during embryonic stages of development can affect many neurodevelopmental 
processes. In the developing zebrafish, exposure to nicotine was reported to cause axonal 
pathfinding errors in the later born secondary motoneurons (SMN). These alterations in SMN 
axon morphology coincided with muscle degeneration at high nicotine concentrations (15–30µM). 
Previous work showed that the paralytic mutant zebrafish known as sofa potato, exhibited 
nicotine-induced effects onto SMN axons at these high concentrations but in the absence of any 
muscle deficits, indicating that pathfinding errors could occur independent of muscle effects.
In this study, we used varying concentrations of nicotine at different developmental windows of 
exposure to specifically isolate its effects onto subpopulations of motoneuron axons. We found 
that nicotine exposure can affect SMN axon morphology in a dose-dependent manner. At low 
concentrations of nicotine, SMN axons exhibited pathfinding errors, in the absence of any 
nicotine-induced muscle abnormalities. Moreover, the nicotine exposure paradigms used affected 
the 3 subpopulations of SMN axons differently, but the dorsal projecting SMN axons were 
primarily affected. We then identified morphologically distinct pathfinding errors that best 
described the nicotine-induced effects on dorsal projecting SMN axons. To test whether SMN 
pathfinding was potentially influenced by alterations in the early born primary motoneuron 
(PMN), we performed dual labeling studies, where both PMN and SMN axons were 
simultaneously labeled with antibodies. We show that only a subset of the SMN axon pathfinding 
errors coincided with abnormal PMN axonal targeting in nicotine-exposed zebrafish. We conclude 
that nicotine exposure can exert differential effects depending on the levels of nicotine and 
developmental exposure window.
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Exposure to nicotine, a potent cholinergic agonist, during embryogenesis causes paralysis in 
zebrafish embryos and larvae. The nicotine-induced paralysis coincides with pronounced 
alterations in motoneuron (Svoboda et al., 2002; Menelaou and Svoboda, 2009) and muscle 
development (Welsh et al., 2009). In developing chick and zebrafish, motoneuron axon 
growth and muscle development occur simultaneously and involve activity-dependent 
mechanisms (Hanson and Landmesser, 2004; Plazas et al., 2013), calcium signaling 
(Brennan et al., 2005), and multiple myotome-derived cues (Zeller et al., 2002; Schweitzer 
et al. 2005; Schneider and Granato, 2006; Palaisa and Granato, 2007).
In the presence of nicotine, both neuronal and muscle tissues can be severely affected by 
activation of nicotinic acetylcholine receptors (nAChRs) (Welsh et al., 2009). In zebrafish 
embryos, acetylcholine-generated calcium transients regulate muscle fiber development 
(Brennan et al., 2005). Following prolonged activation of skeletal muscle via over-activation 
of nAChRs present on muscle, motor axon defects and muscle degeneration occur (Lefebvre 
et al., 2004, Behra et al., 2002), possibly via excitotoxic mechanisms due to increased 
calcium levels in the muscle (Engel et al., 1982; Gomez et al., 2002). This evidence supports 
a direct action of nicotine on muscle fiber development via the activation of muscle-specific 
AChRs.
Sofa potato zebrafish mutants that lack functional skeletal muscle nAChRs (Ono et al., 
2001) exhibited secondary motoneuron (SMN) pathfinding errors without any effects on 
muscle development following embryonic nicotine exposure (15 and 30µM, Welsh et al., 
2009). This suggested that nicotine-induced neuronal and muscle effects can occur 
independently from each other and that muscle fibers are not the sole substrate that nicotine 
acts upon to alter SMN anatomy. These results also indicate that nicotine can directly affect 
cells within the nervous system.
In the following experiments, zebrafish embryos were exposed to different concentrations of 
nicotine at different developmental time windows to determine if nicotine could directly 
alter motoneuron axon morphology, bypassing any muscle defects. The results show that the 
motoneuron and muscle effects uncouple in a dose-dependent manner as a result of either 
short or long duration nicotine exposure window. We then identified four distinct, 
motoneuron axon pathfinding errors that were caused by nicotine exposure, specifically 
affecting dorsal projecting SMN axons. Next, to demonstrate whether these nicotine-induced 
effects were specific to dorsal projecting SMNs, we also examined primary motoneuron 
(PMN) axons which develop first and extend their axons in the muscle prior to SMNs 
(Myers et al., 1986). This became possible following the characterization of a previously 
described antibody developed against the zebrafish β2 nAChR subunit (Welsh et al., 2009). 
We found that this antibody specifically recognizes PMN axons that project ventrally 
(Caudal Primary, CaP) and dorsally (Middle Primary, MiP) into the muscle. With this 
antibody in our toolbox, we were able to simultaneously assess the pathfinding of both PMN 
and SMN axons in the same nicotine-exposed zebrafish. We demonstrate that nicotine 
exposure can affect PMN axon pathfinding which can potentially influence the later born 
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SMN axon morphologies. In addition, a subset of the distinct nicotine-induced SMN 
phenotypes occurred independent of any PMN axon defects suggesting that nicotine 
exposure can specifically affect SMN axon pathfinding.
Materials and Methods
Zebrafish Maintenance
Animal protocols were approved by the Institutional Animal Care and Use Committees at 
Louisiana State University and the University of Wisconsin-Milwaukee. Adult wild-type 
and transgenic (Tg(isl1:GFP), pargmn2Et and Tg(gata2:GFP) fish were maintained at ~28°C 
with a lighting schedule of 14 h light and 10 h dark. Fertilized eggs were obtained from 
natural spawnings of adult zebrafish according to the Zebrafish Book (Westerfield, 1995). 
Embryos were collected within 3 hours of spawning, rinsed, and placed into 100 mm Petri 
dishes containing embryo medium (Westerfield, 1995).
Nicotine Exposures
(−)-Nicotine was purchased from Sigma (St. Louis, Missouri, USA, catalog # N3876-5ml) 
and stock solutions (31.2 mM) were made fresh daily in distilled water. The stock solution 
was then diluted in embryo medium (pH 7.2) to obtain the desired final concentrations. 
Zebrafish embryos while in their chorions were exposed to nicotine (1, 5, 15, and 30µM) 
from 12–30 and 22–72 hours post fertilization (hpf). For all nicotine exposures, the number 
of embryos exposed for each group was the same. At 48 hpf, all nicotine-exposed and stage-
matched control embryos were manually dechorionated and at 72 hpf (larval stage), were 
anaesthetized in MS222 and fixed in 4% paraformaldehyde.
Immunohistochemistry
Whole mount immunohistochemistry was carried out in zebrafish ranging in age from 28 
hpf to 72 hpf that were first fixed in 4% paraformaldehyde overnight at 2–4°C and then 
stored in PBST (PBS containing 0.1% Tween 20). After permeabilization (See Svoboda et 
al., 2001 for details), they were incubated in a primary antibody overnight at 2–4°C. The 
monoclonal antibodies zn5 (also known as zn8) (dilution 1:500), F59 (dilutions 1:100–
1:250) and znp-1 (dilution 1:250) were obtained from the Developmental Studies 
Hybridoma Bank (The University of Iowa, Iowa) and were used to reveal secondary 
motoneuron somata and their axons (Fashena and Westerfield, 1999), slow muscle fibers 
(Devoto et al., 1996), and primary motoneuron axons (Zeller and Granato, 1999), 
respectively. Generation and characterization of the polyclonal anti-β2 nAChR antibody has 
been described previously (Welsh et al., 2009) and was used at a dilution of 1:250. From 
here onward, it will be referred to as anti-chrn2b. The following day, the embryos/larvae 
were washed in PBST for 90 minutes and then incubated for another 90 minutes in an anti-
mouse or anti-rabbit fluorescent secondary antibody conjugated to Alexa 546 or Alexa 488 
(1:1000 dilution in PBST; Molecular Probes, Eugene, OR). The samples were then rinsed in 
PBST for another 60 minutes and prepared for image analysis.
For dual labeling experiments, fish were first incubated with the primary antibody, znp-1 or 
zn5, and then followed by their corresponding anti-mouse fluorescent secondary antibody. 
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Next, fish were washed for 90 minutes in PBST and then incubated with the anti-chrn2b 
antibody overnight at 2–4°C. The next day, following another 90-minute wash in PBST, the 
anti-rabbit fluorescent secondary antibody was added. Lastly, the fish were rinsed in PBST 
for at least 60 minutes prior to imaging.
Image Acquisition and Analysis of Morphological Data
Zebrafish processed via immunohistochemistry were laterally mounted on a slide in PBST, 
lightly cover slipped, and sealed. Single focal plane images (zn5 labeled fish) and image 
stacks (zn5, znp-1, anti-chrn2b and F59 labeled fish) were obtained with an Orca ER CCD 
camera mounted to a Zeiss inverted microscope (Axiovert 200M or Axio Observer) 
equipped with epifluorescence and a Zeiss ApoTome (Carl Zeiss). Images were acquired 
with a 20× dry (0.6 N.A, 0.8 N.A), a 25× water (0.8 N.A.), or a 40× oil (1.3 N.A.) objective. 
Multiple single focal plane images were acquired for each fish capturing motoneuron axon 
morphologies from both sides within each body segment. Image stacks were acquired to 
reveal high-resolution motoneuron axon morphology using volume-rendering software 
(Imaris 5.7.2, Bitplane Inc., Saint Paul, MN).
Evaluation of motoneuron axon morphology following different nicotine exposure 
paradigms was performed on single focal plane images taken from multiple hemisegments 
for control and nicotine-exposed fish. For every fish, we focused our analysis between the 
6th and 20th body segment. Each body segment consists of two hemisegments, one on each 
side of the body. The number of hemisegments imaged and analyzed per fish varied 
depending on the quality of the fish’s lateral mount on the slide.
Each hemisegment typically has one motoneuron nerve bundle that exits spinal cord and its 
axons take three distinct trajectories to the periphery; dorsal, ventral and mediolateral (see 
Fig. 1C). zn5 labeling was used to label SMN axons and if a hemisegment possessed SMN 
axon errors in any of the three axonal trajectories, that hemisegment was then considered 
abnormal. The number of normal hemisegments over the total number of hemisegments 
analyzed per fish was then expressed as a percentage. Each nicotine exposure paradigm was 
replicated multiple times (5 experiments for 22–72 hpf, Supplemental Fig. 1A; 3 
experiments for 12–30 hpf; Supplemental Fig. 1B).
To quantify the effects of nicotine exposure on individual axonal trajectories (dorsal, ventral 
and mediolateral), a subset of the fish analyzed for Figure 2Fi (22–72 hpf exposure window) 
and the fish analyzed for Figure 2Fii (12–30 hpf exposure window) were used. Hence, the 
quantification shown in Table 1 and the subsequent motoneuron phenotyping of the dorsal 
projecting SMN axons was performed from the same experimental dataset for each nicotine 
exposure paradigm. For Table 1, each hemisegment was evaluated for errors in any of the 
three main trajectories (dorsal, ventral and mediolateral). For example, the number of 
hemisegments that possessed abnormal dorsal projecting axons was divided by the total 
number of hemisegments analyzed and was then expressed as a percentage. This 
quantification revealed the relative effects of nicotine on different axonal projections.
Evaluation of muscle fiber morphology was performed using high-resolution image stacks 
following F59 labeling (Welsh et al., 2009). Slow muscle measurements (fiber widths) were 
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acquired using Axiovision 4.7/4.8 (Carl Zeiss) software. For each fish, multiple slow muscle 
fibers were measured but only a single measurement was taken for a given fiber (29.7 ± 5.8 
fibers/fish; mean ± standard deviation). All of the measurements were taken from 2–3 
consecutive hemisegments in the mid body over the yolk sac extension, corresponding to 
body segments 10–15. Each measurement was arbitrarily taken from the fiber and we 
avoided taking measurements from fibers close to the segmental boundary or from muscle 
fibers adjacent to the horizontal myoseptum.
For the characterization of the anti-chrn2b antibody, image stacks were acquired to reveal 
the anti-chrn2b labeling in different transgenic lines or following dual labeling with either 
zn5 or znp-1 antibodies (Supplemental Table 1). Multiple segments from several fish were 
imaged to capture motoneuron morphologies at different developmental stages.
Representative high-resolution photomicrographs shown in the figures were acquired using 
volume-rendering software (Imaris 5.7.2, Bitplane Inc., Saint Paul, MN). Images were 
cropped using Photoshop 7.0 (Adobe, San Jose, CA) and CorelDraw Graphics Suite 12 
(Ottawa, Ontario, CA) was used to organize the figures. All of the images are presented with 
rostral to the left and dorsal to the top. Cartoons were created using CorelDraw by tracing 
axonal trajectories from the photomicrographs.
Statistics
All data were tested for normality prior to statistical analysis. For normally distributed data, 
comparison of the means was performed using one-way analysis of variance (ANOVA), 
followed by a Holm-Sidak post hoc test. For data that failed the normality test, we 
performed a Kruskal-Wallis analysis of variance on ranks, followed by Dunn's post hoc test. 
All multiple comparisons using post hoc tests were performed for each nicotine group 
against the control. All statistical analysis was performed using SigmaPlot 11 (Systat 
Software Inc., San Jose, USA). For each test, we parenthetically report the degrees of 
freedom with its corresponding F or H values according to convention. All values are 
reported as means ± standard error (SE). Significance was assigned at p <0.05 and is 
reported in the figure legends where appropriate.
Results
Previous work examining the effects of embryonic nicotine exposure on SMN axon 
pathfinding has utilized transgenic lines of fish (Tg(isl1:GFP); Tg(gata2:GFP)) and antibody 
markers (zn5) that specifically mark a large subset of secondary motoneurons and their 
axons (Svoboda et al., 2002, Welsh et al., 2009, Menelaou and Svoboda, 2009). These 
secondary motoneurons are positioned mostly in the ventral half of the spinal cord and their 
axons exit at mid-segmental roots where they form a fasciculated nerve fiber. This 
fasciculated bundle of axons then arborizes to innervate the dorsal and ventral myotomes 
(Myers et al., 1986; Menelaou and McLean, 2012). Specifically, the main nerve containing 
SMN axons can either extend dorsally (Fig. 1C, red), ventrally (Fig. 1C, blue) or 
mediolaterally (Fig. 1C, orange) into the myotome (axonal arborizations into the muscle are 
not depicted in Fig. 1C). Recently discovered, a small subset of SMNs has bifurcating axons 
that extend both dorsally and ventrally to arborize into the muscle (not shown on the 
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schematic of Fig. 1C; Menelaou and McLean, 2012). When zebrafish embryos were exposed 
to high concentrations of nicotine, SMN axons exhibited a variety of phenotypes which can 
be clearly visualized using either the Tg(is1:GFP) line of fish (Fig. 1B) or zn5 
immunolabeling (Fig. 1A). These spatially distinct axonal trajectories were more easily 
visualized when the axons were labeled with zn5, which would facilitate identification of 
nicotine-induced alterations in either dorsal, ventral or mediolateral SMN axonal trajectories 
as illustrated in Figure 1D.
Embryonic nicotine exposure can specifically affect secondary motoneuron axons and 
bypass muscle defects
Nicotine exposure in zebrafish from 22–72 hpf has been shown to cause SMN axonal 
pathfinding errors and muscle degeneration at concentrations between 15 and 30µM nicotine 
(Svoboda et al., 2002; Welsh et al., 2009). Here, zebrafish embryos were exposed from 22–
72 hpf at lower concentrations of nicotine (1 and 5µM), in addition to the previously used 15 
and 30µM nicotine concentrations (Fig. 2Bi–Ei), and compared to stage-matched controls 
from the same cohort (Fig. 2Ai). In zebrafish embryos exposed to 1µM nicotine, the dorsal 
projecting SMN axons exhibited subtle misrouting effects such as incorrect navigation at the 
distal part of the myotome (Fig. 2Bi, filled arrow). On the other hand, zebrafish larvae 
exposed to 5, 15, and 30µM nicotine as embryos had SMN axons that appeared to split and 
project in different directions. These phenotypes were observed in the dorsal (Fig. 2Ci–Ei, 
filled arrows), mediolateral (Fig. 2Ci and 2Ei, arrowheads), and ventral (Fig. 2Di and 2Ei, 
open arrows) projecting axons.
Zebrafish myotomal segments were then examined and the abnormal SMN axon phenotypes 
following nicotine exposure (22–72 hpf) were quantified in individual hemisegments (Fig. 
2Fi). If any one of the three main axonal trajectories (dorsal, ventral, or mediolateral 
projecting axons) exhibited abnormal phenotypes in axon trajectory or structure, the 
hemisegment was determined to have abnormal motor axon morphology. There was a 
reduction in the percentage of hemisegments having normal axons in nicotine-exposed fish 
when compared to controls (Fig. 2Fi, one-way ANOVA, F(4,74) = 76.142, p < 0.001, Holm-
Sidak post hoc test). This reduction in normal axons coincided with an increase in axon 
pathfinding errors (Fig. 2Bi–Ei) observed at all concentrations of nicotine tested.
Next, we analyzed the muscle in order to determine if the nicotine-induced effects at these 
different concentrations were specific to SMN axons. The morphology of slow muscle fibers 
was used as readout for nicotine-induced muscle defects (Welsh et al., 2009) utilizing the 
F59 antibody to specifically label them (Devoto et al., 1996). At high nicotine 
concentrations (15 and 30µM, 22–72 hpf exposure window), slow muscle morphology (Fig. 
3Ci and Di) appeared abnormal which coincided with errors in SMN axonal pathfinding 
(Fig. 2Di–Ei, and Fi). Moreover, the overall widths of the F59-positive slow muscle fibers 
from nicotine-exposed (15 and 30µM) fish were thinner (Fig. 3Ci and Di) than slow muscle 
fibers from control fish (Fig. 3Ai and Di; Kruskal-Wallis one-way ANOVA on ranks, H(4) = 
276.527, p < 0.001, Dunn’s post hoc test). However, at lower nicotine concentrations (1 and 
5µM, Fig. 3Bi and Di), muscle morphology was normal since the slow muscle fiber widths 
were similar to slow muscle fiber widths of stage-matched controls (Fig. 3Di). These 
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findings suggest that the axonal pathfinding errors caused by 1 and 5µM nicotine 
concentrations could be neuronal-specific effects.
In order to determine if nicotine exposure could still exert its effects on SMN axons, even if 
exposed at earlier developmental stages, we performed nicotine exposures (1–30µM) from 
12–30 hpf and then examined SMN axon morphology at 72 hpf. At 12 hpf, zebrafish 
embryos are approximately at the beginning of neurulation and well before any motoneurons 
extend their axons into the periphery. The nicotine exposures were terminated at 30 hpf, 
shortly after SMN axons begin their extension into the periphery. The embryos were then 
raised in fresh embryo medium to 72 hpf. In this short window of exposure, the 15 and 
30µM concentrations of nicotine exposure resulted in a reduction of hemisegments with 
normal axons (Fig. 2Fii; one-way ANOVA, F(4,25) = 10.714, p < 0.001, Holm-Sidak post 
hoc test) which coincided with an increase in axon pathfinding errors (Fig. 2Dii and 2Eii, 
arrows) when compared to controls. In larvae exposed to low nicotine concentrations (1 and 
5µM) as embryos, SMN axons projected normally into the periphery (Fig. 2Bii and 2Cii) 
and were indistinguishable from their control counterparts (Fig. 2Aii). The quantification of 
individual experiments revealed that even the control fish appeared to possess abnormal 
motoneuron axon trajectories. Thus, we acknowledge that some of the nicotine-induced 
effects appeared subtle in nature and could be within the normal range of developmental 
variability. However, our experimental design accounted for such possibility by carrying out 
nicotine exposure experiments with fish from the same cohort. Comparisons of nicotine 
effects were never performed against control groups from different cohorts.
In a different set of experiments, we examined the morphology of the F59-positive, slow 
muscle fibers following nicotine exposure between 12–30 hpf (Fig. 3Aii–Dii). The width of 
slow muscle fibers from nicotine-exposed fish appeared normal with no differences in width 
when compared the slow muscle fibers widths from control zebrafish at all concentrations 
tested (Fig. 3Dii; Kruskal-Wallis one-way ANOVA on ranks (H(4) = 15.323; p=0.004), 
Dunn’s post hoc test). This suggests that SMN axon pathfinding was mostly affected only 
when embryos were exposed to high concentrations of nicotine between 12–30 hpf while 
muscle morphology still appeared normal. It further suggests that the earlier and shorter 
exposure window (12–30 hpf) can lead to axonal effects that are specific to motor axons and 
thus potentially bypass any muscle defects.
Nicotine exposure mainly affects the dorsal projecting secondary motoneuron axons
While using different nicotine exposure paradigms, it became clear that SMN axons were 
being affected differently. In order to investigate the differential effects of nicotine, we first 
focused on its effect on the different axonal trajectories (dorsal, ventral and mediolateral) 
but also by the nature of the pathfinding errors (Fig. 2). Based on this, we first quantified the 
nicotine-induced effects on SMN axons specifically for dorsal, ventral, and mediolateral 
projecting axons for each hemisegment. We found that among the three main motoneuron 
axon trajectories, nicotine exposure between 22–72 hpf primarily affected the dorsal 
projecting SMN axons at all nicotine concentrations (Table 1). At the higher nicotine 
concentrations (15 and 30µM), the ventral and mediolateral projecting axons were also 
significantly affected when compared to their control counterparts. Similar differential 
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nicotine-induced target effects were observed following the 12–30 hpf exposure window. In 
those zebrafish, the ventral and mediolateral SMN axons projected normally, but the dorsal 
SMN axons did not (Table 1). These findings suggest that dorsal projecting SMN axons are 
more susceptible to nicotine exposure than ventral and mediolateral projecting SMN axons. 
It also suggests that different mechanisms possibly underlie the actions of nicotine. 
Consequently, we focused our analysis on the dorsal projecting SMN axons regardless of the 
nature of the pathfinding error (Fig. 4A). It became clear that the percent of dorsal projecting 
SMN axons with abnormal pathfinding phenotypes was increased for all nicotine 
concentrations between 22–72 hpf (Fig. 4B; one-way ANOVA, F(4,43) = 60.494, p < 0.001, 
Holm-Sidak post hoc test). However, if embryos were exposed from 12–30 hpf, abnormal 
SMN axonal phenotypes only occurred at high nicotine concentrations (15 and 30µM; Fig. 
4B, Kruskal-Wallis one-way ANOVA on ranks, H(4) = 16.859; p=0.002, Dunn’s post hoc).
Nicotine-induced pathfinding phenotypes of dorsal projecting secondary motoneuron 
axons
In order to better understand the differential effects of nicotine exposure on SMN axonal 
pathfinding, the dorsal projecting SMN axon pathfinding errors were categorized based on 
the nature of their phenotype. Four phenotypically distinct, nicotine-induced axonal 
pathfinding errors emerged which describe deficits in SMN axon pathfinding and myotomal 
targeting (Fig. 5). The first of the abnormal phenotypes was characterized by distinct errors 
in axon trajectory. Dorsal projecting axons that belong in this group appear to successfully 
reach their dorsal-most targets in the periphery. However, in some cases as they exit the 
spinal cord they fail to turn dorsally at the appropriate intermediate turning point (Fig. 5B, 
arrowheads; compare to control in Fig. 5A right panel). Instead, they often extended far 
caudally past that point before turning dorsally. In other cases, the dorsal projecting axon 
exhibited very distinct sharp turns (Fig. 5B, arrows) as they navigated within the myotome. 
Therefore, if SMN axons exhibited any of the aforementioned errors, they were classified as 
having “trajectory” errors.
The second phenotypically distinct SMN axonal pathfinding error describes dorsal 
projecting SMN axons that exhibited a “fork”-like (split) phenotype as they projected into 
the dorsal myotome (Fig. 5C, filled arrows). In these cases, a subset of axons separated from 
the main dorsal SMN nerve bundle and extended in different directions. This resulted in the 
axons splitting along two different paths which yielded the “split” axon phenotype.
The third distinct pathfinding error caused by nicotine exposure was the “stall” axon error. 
This phenotype was characterized by dorsal projecting axons that stalled at the turning point 
and then failed to fully reach the dorsal periphery (Fig. 5D, circle). In some cases, even 
though it was evident that the dorsal projecting axons stalled at the ventral root (Fig. 5D), a 
subset of dorsal projecting axons could be detected, and appeared as very thin fibers (Fig. 
5D, arrowheads).
Following this careful description of dorsal SMN axon phenotypes caused by nicotine 
exposures, we specifically examined dorsal projecting axons according to phenotypically 
distinct errors. We found that the “trajectory” error phenotypes occurred at all nicotine 
concentrations between 22–72 hpf (Fig 6A; one-way ANOVA, F(4,43) = 23.755, p < 0.001, 
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Holm-Sidak post hoc test), whereas when exposed between 12–30 hpf only high 
concentrations of nicotine (15 and 30µM) affected dorsal SMN axons (Fig. 6A; one-way 
ANOVA, F(4,25) = 5.044, p = 0.004, Holm-Sidak post hoc test). Also, dorsal projecting 
axons in fish exposed between 22–72 hpf exhibited the “split” error phenotype 
predominately at 5 and 15µM nicotine exposure (Fig. 6B; Kruskal-Wallis one-way ANOVA 
on ranks, H(4) = 27.406; p<0.001, Dunn’s post hoc). However, the “stall” axon phenotype 
mostly occurred in fish exposed to 30µM nicotine and less when exposed to 1 and 15µM 
nicotine from 22–72 hpf (Fig. 6C; Kruskal-Wallis one-way ANOVA on ranks, H(4) = 
29.627; p<0.001, Dunn’s post hoc). Taken together, these results indicate that a 1µM 
nicotine exposure from 22–72 hpf as well as 15 and 30µM nicotine from 12–30 hpf 
primarily cause “trajectory” errors.
Lastly, a fourth phenotypically distinct pathfinding error caused by nicotine exposure, which 
could not easily fit into the other 3 categories, was the duplication of SMN ventral 
projecting nerve bundles within a hemisegment (Supplemental Fig. 2A and B). Even though 
these duplicated axons projected ventrally, they were confined within the dorsal myotome 
and did not extend their axons beyond the midline into the ventral myotome. This phenotype 
occurred more frequently in 30µM nicotine-exposed zebrafish and was only evident when 
the exposure window was from 22–72 hpf (Supplemental Fig. 2B).
A subset of primary motoneurons can be visualized using the β2 nAChR antibody
We have presented four distinct SMN axonal phenotypes in larval zebrafish caused by 
embryonic nicotine exposure. Specifically, the “trajectory” errors in SMN axons occur in 
approximately 50% of the segments analyzed when exposed to nicotine between 22–72 hpf 
at low concentrations (1µM). Similar errors occurred when embryos were exposed at higher 
concentrations of nicotine (15 and 30µM) between 12–30 hpf and then analyzed at 72 hpf. 
Interestingly, during the shorter and earlier exposure window (12–30 hpf) nicotine was 
withdrawn prior to most SMN axons exiting the spinal cord and extending in the dorsal 
myotome. Therefore, we hypothesized that nicotine may affect earlier born dorsal projecting 
motoneurons that undergo axon extension during this early time window. It was previously 
shown that primary motoneurons are among the earliest born and their axonal trajectory 
paths are used by SMNs as a guide at later stages (Pike et al., 1992). We asked then whether 
nicotine exposure affected the dorsal projecting primary motoneuron axon (MiP, Middle 
Primary), which could then influence dorsal projecting SMN axons and thus manifest as 
“trajectory” errors when visualized using the zn5 antibody.
In order to test this possibility, we used an antibody (anti-chrn2b) designed to target β2 
nAChR subunits in a previous study (Welsh et al. 2009) to specifically label the dorsally 
projecting PMN axon. In that study, the β2 nAChR subunit was detected on zebrafish 
Rohon-Beard neurons and motoneuron axons. In the current study, we used a series of 
immunolabeling experiments to demonstrate that this antibody labels a subset of PMNs; 
specifically the CaP (Caudal Primary) and MiP (Middle Primary) motoneuron somata and 
axons (Fig. 7, n= 177 embryos and larvae, Supplement Table 1). Immunolabeling at 28 hpf 
with the β2 nAChR antibody labels the CaP somata and its axon (Fig. 7A; open and filled 
arrows indicate the soma and axon, respectively) and by 30–32 hpf, a dorsal projecting axon 
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can be detected (Fig. 7B and C, yellow arrow). Occasionally, anti-chrn2b labeling detected 
large cell bodies adjacent to CaP somata which were likely presumptive MiP cell bodies 
(Fig. 7C, yellow circle).
Dual immunostaining at 28 hpf with anti-chrn2b along with the znp-1 antibody which is 
primarily used to label PMN axons, revealed co-labeling on the same ventrally projecting 
axon (CaP axon) (Fig. 7D, E). However, co-staining at 31 hpf with anti-chrn2b and the zn5 
antibody which labels SMN axons (Fig. 7F) revealed two non-overlapping ventrally 
projecting axons. These expression profiles suggest that anti-chrn2b labels the zn5-negative, 
CaP axon. At timepoints between 31 and 36 hpf, the same dorsally projecting axon was co-
labeled with the znp-1 antibody and anti-chrn2b (Fig. 7G–I; Supplemental Fig. 3A–C). This 
suggested that this dorsally projecting, anti-chrn2b positive axon, at these early 
developmental stages was most likely the MiP axon.
To further substantiate anti-chrn2b labeling of the MiP axon, we performed anti-chrn2b 
immunostaining in pargmn2Et zebrafish, which express green fluorescent protein (GFP) in 
motoneurons early in embryogenesis (Balciunas et al., 2004). At 24 hpf, GFP-positive MiP 
axons in pargmn2Et are readily detected (Fig. 7J, white arrows). This was true for 28 hpf, 32 
hpf, and 36 hpf embryos (data not shown). When 34 hpf pargmn2Et embryos (Fig. 7K–M) 
were labeled with anti-chrn2b, the putative MiP axons (Fig. 7K and 7L) as well as the CaP 
axons (not shown) were labeled. These experiments using pargmn2Et embryos validated the 
results from the labeling studies using znp-1 and anti-chrn2b. The anti-chrn2b antibody is 
most likely labeling both CaP and MiP axons which would be a useful tool to facilitate dual 
labeling studies in the same embryo/larva to simultaneously examine nicotine effects on 
PMN axons (anti-chrn2b labeling) along with SMN axons (zn5 labeling).
In order to use the anti-chrn2b to label putative PMN axons, we first confirmed that even at 
later developmental time points (36–72 hpf), the anti-chrn2b labeling was still robust 
(Supplemental Fig. 3A–C for 36 hpf embryo) and was confined to PMN axons. In 48-hpf 
embryos, the znp1-positive, main ventral projecting axon, still appeared to colocalize 
directly with the anti-chrn2b signal (not shown). However, dual labeling with the zn5 
antibody and anti-chrn2b revealed no apparent colocalization of the two markers on a single 
ventral projecting motor axon (Supplemental Fig. 3D–E). Moreover, at 48 hpf, the dorsal 
projecting, zn5-positive SMN axons still have not projected to the periphery, but anti-
chrn2b is clearly detecting a dorsal projecting axon at this stage; which is likely the MiP 
axon. In the transgenic zebrafish line, Tg(gata2:GFP), which express GFP in ventral 
projecting SMN axons, anti-chrn2b did not label the ventral projecting, GFP-positive SMN 
axon (Supplemental Fig. 3F).
By 72 hpf, the zn5-positive dorsal projecting SMN axons can now be easily detected in the 
periphery. These axons did not appear to colocalize with the anti-chrn2b-positive axon 
(likely MiP; denoted by white circle in Supplemental Fig. 3G) in the dorsal periphery, as 
there is a clear separation between the labeled axons. However, as the zn5-positive axons 
first exited spinal cord, they appeared to overlap tightly with the anti-chrn2b positive MiP 
axon (Supplemental Fig. 3G, white arrow).
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Uncoupling nicotine-induced pathfinding errors in primary and secondary motoneuron 
axons
Double labeling studies were performed in embryos exposed to nicotine using the same 
exposure windows and concentrations presented earlier in this study (n=116, Supplement 
Table 1). Immunolabeling with zn5 and anti-chrn2b at 72 hpf in control larva shows that the 
dorsal zn5-positive SMN axons take the same trajectory to the periphery as the chrn2b-
positive MiP axon (Fig. 8A–C). Based on the dose response and exposure window for 
nicotine, the SMN “trajectory” errors could be replicated by using high nicotine 
concentrations (30µM, Fig. 8D–F) between 12–30 hpf as well as low (1µM, Fig. 8G–I) or 
high (30µM, Fig. 8J–L) nicotine concentrations between 22–72 hpf. These larvae exhibited 
SMN axonal trajectory errors as denoted by the yellow arrows (see Fig. 8D, G and J) and 
were accompanied by errors in the anti-chrn2b positive MiP-like axon. Whenever a true 
“trajectory” error was present in SMN axons (yellow arrows in figure 8), the corresponding 
PMN axons exhibited the same trajectory error regardless of the window of exposure or 
concentration of nicotine.
We then determined if any of the other nicotine-induced SMN axonal phenotypes were 
potentially linked to altered PMN axon morphology as it appeared that SMN axons were 
following the lead of PMN axons as they exited spinal cord and entered the periphery. When 
SMN axons were stalled entering the periphery (Fig. 9A, yellow arrows), PMN axons were 
still observed to extend well into the periphery; they did not retract (Fig. 9B–C). The 
nicotine-induced duplication of SMN axon nerve roots (Fig. 9D, yellow arrow) was 
observed in segments where ventral projecting PMN axons clearly were not duplicated (Fig. 
9E). In fact, duplicated PMN axons have not been observed in any of our nicotine studies.
Interestingly, in some segments, the SMN nerve bundle appeared to stall but seemed to have 
a single axon that was navigating into the dorsal periphery. This single SMN axon still 
appeared to use the anti-chrn2b-positive PMN axon (MiP) as a guide. In this case, the PMN 
axon appeared to properly orientate the SMN axon towards the dorsal periphery (Fig. 10A–
C; magnified views shown in Fig. 10D–F). Thus, consistent with data shown in figure 9, the 
putative MiP axon was acting as a guide for dorsal projecting SMN axons especially when 
in proximity to the ventral nerve exit point (Fig. 10A, D, asterisk). However, once SMN 
axons navigated distally in the dorsal periphery (Fig. 10I, yellow arrow), the nicotine-
induced errors could occur independent of the corresponding PMN axon. (Fig. 10I, white 
arrow). Lastly, when SMN axons had a “split” axon error within the dorsal periphery, the 
corresponding PMN axon within that segment did not appear to have branches extending 
from it that would influence the SMN axons causing them to take “wrong” directions to the 
periphery (not shown).
Discussion
In this study, we show that motoneuron axon pathfinding errors and muscle degeneration in 
zebrafish depend on the concentration of nicotine, along with the length and developmental 
window of the exposure. We demonstrate that nicotine exposure not only can affect axons of 
different motoneuron subtypes but can also differentially influence axons within a given 
motoneuron subtype that projects either dorsally, ventrally or mediolaterally into the muscle. 
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We also reveal that nicotine can differentially affect muscle morphology which could 
potentially influence motor axon pathfinding. Additionally, we show that nicotine exposure 
can lead to morphologically distinct phenotypes for dorsal projecting motoneuron axons. 
These results highlight the potentially intricate actions of nicotine and provide needed 
insight for understanding potential mechanisms underlying nicotine-induced axonal 
pathfinding errors.
Uncoupling axonal pathfinding errors and muscle degeneration
In zebrafish, primary and secondary motoneurons extend their axons in a stereotypical 
manner to reach their appropriate target muscles. They navigate into the periphery with 
remarkable precision and any alterations in the intrinsic or extrinsic factors that help guide 
them, can lead to pathfinding errors. The earliest born motoneurons (PMNs) in zebrafish 
begin extending their axons in the myotome at ~16–17 hpf and make functional contacts 
with the slow muscle fibers around that time; at ~24 hpf SMN emerge and follow the PMNs 
(Myers et al., 1986; Eisen et al., 1986; Jackson and Ingham, 2013). Muscle fibers possess 
nicotinic acetylcholine receptors which makes them susceptible to nicotinic insult. 
Therefore, when investigating the neuronal effects of nicotine in a whole developing system, 
it is important to account for potential nicotine-induced effects on muscle fiber morphology 
(Welsh et al., 2009). In this study, we show that nicotine-induced axonal pathfinding errors 
can occur in the presence or absence of muscle defects depending on the concentration of 
nicotine and the window of exposure. When wildtype zebrafish were exposed from 22–72 
hpf to 15 and 30µM nicotine, axonal pathfinding abnormalities and muscle degeneration 
occurred concurrently. However, when zebrafish were exposed to lower concentrations of 
nicotine (1 and 5µM, 22–72 hpf), abnormalities in axonal targeting were present even in the 
absence of quantifiable muscle defects.
Since the axonal pathfinding errors appeared to be far more robust at nicotine concentrations 
that also caused muscle degeneration, it is possible that muscle defects could influence 
motoneuron axon pathfinding. It is widely accepted that nerve-muscle interactions are 
important for proper axon growth and target selection (Funakoshi et al., 1995). In zebrafish, 
proper migration and guidance of spinal motor axons are dependent upon certain muscle-
derived cues (Feldner et al., 2005; Schweitzer et al., 2005; Schneider and Granato, 2006). 
Nicotine-induced abnormalities in muscle morphology may impair the ability of the muscle 
to provide the appropriate cues back to the spinal motor axons. In this scenario, the axons 
would either be misrouted to inappropriate targets or potentially stalled at intermediate 
target points (Knobel et al., 1999).
Notably, zebrafish embryos exposed to nicotine from 12–30 hpf did not exhibit slow muscle 
degeneration at nicotine concentrations that usually resulted in muscle morphology defects 
when exposed between 22–72 hpf. The transcript for the zebrafish muscle receptor β1 
subunit has been shown to be robustly unregulated between 48–72 hpf (Papke et al., 2012). 
Such differences in the level of muscle nicotinic receptor expression could account for the 
differential effects of nicotine on muscle fibers at different stages of development. Hence, 
when exposed from 12–30 hpf, the nicotine effects on muscle may be minimal even at high 
concentrations of nicotine due to the inherently low levels of functional muscle receptors. 
Menelaou et al. Page 12













However, if the nicotine exposure largely overlaps with the increase in muscle receptor 
levels (22–72 hpf exposure window), this could result in receptor over-activation and thus 
muscle degeneration. Alternatively, compensatory mechanisms may also account for the 
lack of muscle defects when embryos were exposed from 12–30 hpf. Embryos were 
removed from nicotine at 30 hpf which may have allowed any affected slow muscle fibers to 
recover and exhibit normal muscle morphology by 72 hpf. Taken together, these results 
suggest that nicotine can potentially influence neuronal and muscle effects independently. In 
the absence of muscle effects, the nicotine-induced SMN axonal targeting errors appeared 
more subtle, but were still evident providing further support for the neural specific actions of 
nicotine (Svoboda et al, 2002).
Nicotine-induced effects on dorsal, ventral, and mediolateral projecting SMN axons
Nicotine-induced motoneuron axon pathfinding errors were mostly associated with the 
dorsal projecting axons rather than the ventral and mediolateral projecting ones. Ablation 
experiments in zebrafish have shown that in the absence of ventral primary motoneurons 
(CaP), SMN extend their axons properly and reach their targets (Pike et al., 1992). However, 
in the absence of the MiP motoneurons, dorsal projecting SMN axons often extend into the 
periphery along incorrect paths. Importantly, SMN axons exit the spinal cord in a sequential 
manner. First, ventral SMNs extend their axons, followed by the mediolateral projecting 
SMN axons and lastly by the dorsal projecting axons (Ott et al., 2001). Such differences in 
the timing of axon extension could contribute to errors seen mainly on dorsal projecting 
axons following the different nicotine exposure windows. Therefore, each nicotine exposure 
in combination with the levels of nicotine may exert differential effects depending on when 
SMN axons have already exited the spinal cord. Moreover, motoneurons that project axons 
dorsally, express different transcription factors compared to those motoneurons that have 
ventrally projecting axons, enabling them to use distinct signaling cues and pathways for 
axon extension and targeting (Guthrie, 2007; Sharma et al., 2000). This differential ability of 
dorsal, ventral, and mediolateral SMN axons to establish their normal pathways suggests 
that different guidance cues govern path choice. Consequently, nicotine exposure could alter 
signaling pathways and guidance cues specifically required for dorsal projecting SMN axons 
to make correct path choices.
It is known that nicotine can directly act upon presynaptic nAChRs and affect motoneuron 
axon branching via presynaptic mechanisms (An et al., 2010). Even though the 
developmental expression profile of nAChR subunits has been described in zebrafish (Zirger 
et al., 2003; Ackerman et al., 2009; Menelaou et al., 2014), the exact spatiotemporal and 
combinatorial profile of nAChRs still remains unknown. nAChRs are assembled in a wide 
range of subunit combinations and they exhibit differences in Ca+2 permeability, channel 
kinetics, desensitization rate and agonist/antagonist sensitivity (Kalamida et al., 2007). 
Interestingly, nicotine has been shown to be most potent and efficacious in activating the 
zebrafish α4β2 receptor subtype as compared to other heteromeric β2-containing nAChR 
subtypes, when expressed and analyzed in Xenopus oocytes (Papke et al., 2012). Thus, it is 
possible that the localization of different of nAChR subtypes to dorsal, ventral or 
mediolateral SMN axons can directly influence nicotine’s ability to alter SMN axonal 
pathfinding; with some axons being more severely affected than others.
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Possible mechanisms underlying nicotine-induced motoneuron axon phenotypes
The differential effects of nicotine on motoneuron axons indicate that the actions of nicotine 
are multifaceted. One possible explanation for the nicotine-induced effects observed in SMN 
axons could be due to alterations of calcium homeostasis, which can then inappropriately 
affect downstream Ca2+-mediated signaling pathways critical in the expression of intrinsic 
molecules. The frequency and strength of Ca2+ transients has been shown to effectively 
modulate gene activity and differentially activate signaling pathways (Dolmetsch et al., 
1997; Greer and Greenberg, 2008). Therefore, inappropriate nicotine-induced activation of 
nAChRs at critical developmental stages may disrupt the normal course of gene expression, 
thus disrupting the expression profiles of axon pathfinding-specific molecules. Another 
possible mechanism may involve altering muscle-derived or environmental cues important 
for axon pathfinding.
The motoneuron axonal “trajectory” errors were among the most commonly observed axon 
pathfinding errors following nicotine exposures (12–30 hpf and 22–72 hpf). Even though 
these trajectory errors occurred at all nicotine concentrations when exposed between 22–72 
hpf, that was not the case for the short exposure window. Given that the trajectory errors 
were still likely to occur at concentrations that muscle morphology was not affected, we 
argue that the “trajectory” errors could potentially be caused by nicotine independent of 
muscle defects. In this context, there are at least two possible mechanisms that could 
produce the trajectory errors observed in zebrafish upon nicotine exposure. First, altering the 
frequency of rhythmic bursting activity during motoneuron axon outgrowth can result in 
pathfinding errors (Hanson and Landmesser, 2004, 2006). Zebrafish embryos exhibit robust 
spontaneous activity between 17–28 hpf (Saint-Amant and Drapeau, 1998, Thomas et al., 
2009). This intrinsic spontaneous activity is associated with Ca2+ transients in the 
motoneuron soma and growth cones (Plazas et al., 2013; Hanson and Landmesser, 2003) 
and results in the activation of muscle nicotinic receptors by the release of acetylcholine 
(Wang et al., 2009). We also know that transient nicotine exposure dramatically increases 
the embryonic motor activity in zebrafish (Thomas et al., 2009). Therefore, nicotine 
application during motoneuron development and axon outgrowth can alter the frequency of 
the motoneuron bursting activity through activation of spinal nAChRs, and potentially 
disrupt motor axon pathfinding decisions in zebrafish.
Alteration of calcium homeostasis can potentially affect both primary and secondary 
motoneurons. Therefore, an alternative mechanism underlying the “trajectory” errors could 
involve nicotine-induced alterations of PMN axons that extend first even before SMNs start 
extending their axons into the periphery. This would subsequently result in the abnormal 
pathfinding of SMN axons. In zebrafish, it is known that secondary motoneurons extend 
their axons following a path previously established by primary motoneurons (Pike et al., 
1992). In some of the experiments reported here, zebrafish embryos were exposed to 
nicotine before the dorsal projecting primary motoneuron (MiP) axons start to extend in the 
dorsal myotome. If nicotine exposure altered the normal trajectory of MiP axons, this could 
influence SMN axon pathfinding. For example, SMN dorsal projecting axons could follow 
the incorrect path set by MiP axons and at 72 hpf, this would be detected as a “trajectory” 
error. Our examination of PMN and SMN axons in the same fish using the anti-chrn2b 
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antibody revealed that these nicotine-induced “trajectory” errors were also present in PMNs, 
specifically the MiP axon. As MiP axons exited the spinal cord they drifted further caudal 
than they would normally do, SMNs appeared to follow the same PMN axon tract as they 
exited spinal cord. It appeared that whatever trajectory the MiP axons took when initially 
exiting spinal cord, the SMN axon would use it as a guide and such phenotypes appeared 
similar to those observed in sidetracked mutants where plexin A3 signaling is compromised 
(Palaisa and Granato, 2007).
The nicotine-induced “split” error phenotype was most commonly observed in zebrafish 
when exposed to 5 and 15µM nicotine (22–72 hpf window of exposure), but it was sparsely 
seen in fish exposed from 12–30 hpf. The distinction of this phenotype from the “trajectory” 
errors was the single point bifurcation (split) along the dorsal axon. Similar bifurcation 
behavior of motor axons has been reported for the ventrally projecting primary motoneuron 
axon (CaP) (Sainath and Granato, 2013). In that study, the intrinsic expression of plexin A3 
receptors and an unidentifiable extrinsic cue known as turnout, played important roles in the 
proper and well-timed bifurcation in addition to maintaining the stability of branch points 
for CaP axon. Plexin A3 and turnout are intrinsic and extrinsic cues, respectively, both 
shown to be associated with the ventral CaP axon. If either of them, or some other similar 
cues were affected by nicotine exposure, this would in turn lead to premature axon splitting 
and potentially aberrant branching of dorsal SMN axons.
Following a nicotine exposure paradigm which was associated with muscle degeneration 
(30µM, 22–72 hpf), there was a higher likelihood to observe motoneurons with stalled axons 
at the spinal cord exit point. It is known that axon retraction and growth cone stalling are 
also associated with high frequency Ca2+ transients. When axons stall at intermediate 
decision points, they exhibit a high frequency of Ca2+ transients and when they begin to turn 
and elongate towards their target, Ca2+ transients are abolished (Gomez and Spitzer, 1999). 
Upon nicotine exposure, activation of neuronal and muscle AChRs occurs. This over-
activation of nAChRs during critical periods of axon growth can result in high frequency 
Ca2+ transients, thus leading to axon stalling. In chick ciliary ganglion neurons, activation of 
α-bungarotoxin-sensitive nAChRs by nicotine exposure causes neurite retraction and 
inhibits neurite extension in a calcium-dependent manner (Pugh and Berg, 1994). In 
zebrafish, PMN axons can stall during pathfinding if they lack the stumpy gene. With this 
mutation, PMN axons do not receive the attracting signals from the periphery and this 
prevents them from extending beyond their intermediate targets (Beattie et al., 2000). This 
suggests that altering the frequency of intracellular Ca2+ transients along with changes in the 
muscle-derived cues from the environment (due to muscle degeneration possibly) play 
critical roles in proper axonal extension. However, in the stumpy mutants, only PMN axons 
were analyzed (Beattie et al., 2000), therefore it was not clear whether SMN axons also 
exhibited similar phenotypes. In this study, dorsal-projecting SMN axons were stalled even 
though their corresponding MiP motoneurons had extended their axon into the periphery. 
The nicotine-induced “stall” errors typically occurred at concentrations and exposure 
windows that also caused muscle degeneration. Interestingly, the muscle degeneration did 
not appear to overtly affect PMN axon targeting or morphology which suggests that muscle-
derived cues may not substantially influence PMN axonal targeting to the periphery.
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The presence of duplicated ventral projecting motor axons appearing as additional exit 
points in the dorsal myotome is not unique to the nicotine exposure paradigms reported here. 
In zebrafish, blocking the expression of neuropilin-1 and plexin A3, two receptors that bind 
axon-repelling semaphorins, induces additional exit points of spinal motor nerves from 
spinal cord (Feldner et al., 2005; Palaisa and Granato, 2007). These axon duplications 
mainly occurred within the posterior end of the somite, where semaphorins are highly 
concentrated thus restricting the extension of spinal motor axons in the anterior part of the 
somite. Therefore, if motoneuron axons fail to express axon-repellent receptors, they would 
be unable to detect signals that would normally restrict them from entering the posterior end 
of the somite. In those studies, the primary focus was on PMN axon pathfinding. In our 
experiments, we were able to analyze both PMN and SMN axons in the same fish and found 
that nicotine exposure could result in SMN axons being duplicated when PMN axons in the 
same segment were not. Thus, the exposure was likely directly affecting SMN axons and 
likely affecting signaling mechanisms other than plexin A3 or the semaphorins.
In summary, embryonic nicotine exposure can affect cholinergic signaling and consequently 
lead to motoneuron axon pathfinding errors of spatially distinct axonal trajectories in 
zebrafish. Different types of motoneurons (PMNs and SMNs) exhibited phenotypically 
distinct axonal alterations following exposure to nicotine and the mechanisms underlying the 
nicotine-induced effects most likely involve complex intrinsic and extrinsic pathways. 
However, the specific mechanisms underlying the actions of nicotine on neural and muscle 
substrates is unclear and still remains to be examined in the future.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Embryonic nicotine exposure can specifically affect secondary motoneuron axons in a 
dose-dependent manner.
The nicotine-induced secondary motoneuron axonal pathfinding errors can occur 
independent of any muscle fiber alterations.
Nicotine exposure primarily affects dorsal projecting secondary motoneurons axons.
Nicotine-induced primary motoneuron axon pathfinding errors can influence secondary 
motoneuron axon morphology.
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Figure 1. Secondary motoneuron axons and the effects of nicotine exposure on their axonal 
pathfinding
A) Photomicrograph of a 72-hpf larval Tg(isl1:GFP) zebrafish immunolabeled with the zn5 
antibody (red) which specifically labels the main nerve of fasciculated SMNs axons. This 
zebrafish was exposed to nicotine (30µM) embryonically (22–72 hpf) and exhibits axonal 
pathfinding errors in 4 consecutive segments. B) zn5 immunostaining is shown in the 
Tg(isl1:GFP) larval zebrafish that expresses GFP (white) in a subset of secondary 
motoneurons (SMN). Zn5-positive axons colocalize with GFP-positive dorsal projecting 
SMN axons. C) Left segment shows a lateral view of different subpopulations of secondary 
motoneurons (SMNs, shown in orange, red and blue) located in ventral spinal cord (marked 
by dotted lines). Axons exit at mid-segmental root and extend dorsally (D, red), ventrally 
(V, blue), and mediolaterally (ML, orange). Right segment illustrates normal pathfinding of 
SMN axons as visualized by zn5 labeling. D) Examples of abnormal axonal pathfinding are 
shown in each segment in the dorsal and ventral myotome. Note that abnormal phenotypes 
can be seen for dorsal, ventral, and mediolateral projecting axons. Horizontal myoseptum: 
hm. Illustration is not drawn to scale. Scale bar, 20 µm.
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Figure 2. Nicotine-induced effects on SMN axons depend upon nicotine concentration and 
window of exposure
Ai) Zn5 immunoreactivity reveals SMN axons and their somata in 72-hpf control larva and 
corresponding zebrafish larvae exposed to varying concentrations of nicotine, 1µM (Bi), 
5µM (Ci), 15µM (Di) and 30µM (Ei) from 22–72 hpf. Note the abnormal motoneuron axon 
trajectories in the nicotine-exposed zebrafish when compared to their control counterparts. 
Fi) At 72 hpf, the number of hemisegments with motoneuron axons that projected normally 
in the dorsal, ventral, and mediolateral myotomes over the total number of hemisegments 
analyzed in each fish was quantified and expressed as a percentage. Zebrafish exposed to 
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1µM (516 segments; 18 fish), 5µM (355 segments; 14 fish), 15µM (436 segments; 16 fish), 
and 30µM nicotine (359 segments; 14 fish) exhibited more hemisegments with abnormal 
motoneuron axon morphologies when compared to their stage-matched controls (455 
segments; 17 fish). Asterisks in Fi denote statistical significance, p value < 0.001. Nicotine 
groups compared against the control using a post hoc Holm-Sidak test. Aii–Eii) Same as in 
Ai–Ei but for nicotine exposure window between 12–30 hpf. Fii) Quantification of nicotine-
induced effects on SMN axons for exposure window 12–30 hpf. Zebrafish exposed to 1µM 
(176 segments; 7 fish) and 5µM nicotine (139 segments; 6 fish) were not significantly 
affected whereas when exposed at 15µM (125 segments; 5 fish) and 30µM (146 segments; 6 
fish) were affected when compared to stage-matched controls (152 segments; 6 fish). Filled 
arrows indicate pathfinding errors in dorsal projecting axons. Open arrows indicate 
pathfinding errors in ventral projecting axons. Arrowheads indicate errors in ventromedial 
projecting axons. Quantification shown in Fi and Fii is from a single representative 
experiment for each nicotine exposure paradigm (also see, Supplemental Fig.1). Asterisks in 
Fii denote statistical significance, p value < 0.05. Nicotine groups were compared against 
the control using a post hoc Dunn’s test. Scale bars, 20 µm.
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Figure 3. Morphology of slow muscle fibers following nicotine exposure
F59 immunoreactivity was used to reveal slow muscle fibers in 72-hpf zebrafish larvae 
exposed to varying concentrations of nicotine. Representative photomicrographs reveal 
multiple slow muscle fibers in the field of view from control larvae (Ai) and corresponding 
zebrafish larvae exposed to 1µM (Bi) 30µM (Ci) nicotine from 22–72 hpf. Di) 
Quantification of slow muscle fiber widths in 72 hpf zebrafish for exposure window 
between 22–72 hpf (control: 268 muscle fibers, 7 fish; 1µM: 237 muscle fibers, 7 fish; 5µM: 
165 muscle fibers, 5 fish; 15µM: 207 muscle fibers, 7 fish; 30µM: 198 muscle fibers, 7 fish). 
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Aii–Cii) Same as in Ai–Ci but for nicotine exposure window between 12–30 hpf. Dii) 
Quantification of slow muscle fiber widths in 72-hpf zebrafish for exposure window 
between 12–30 hpf (control: 363 muscle fibers, 12 fish; 1µM: 256 muscle fibers, 10 fish; 
5µM: 463 muscle fibers, 16 fish; 15µM: 398 muscle fibers, 13 fish; 30µM: 204 muscle 
fibers, 9 fish). Asterisk denotes statistical significance, p value < 0.05. Nicotine groups were 
compared against the control using a post hoc Holm-Sidak test. Scale bars, 20 µm.
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Figure 4. Effect of embryonic nicotine exposure on dorsal projecting SMN axons
A) Drawings depict a normal SMN axon projecting dorsally (grey) superimposed with 
observed nicotine-induced abnormal phenotypes (black). B) Dorsal projecting axons in 72-
hpf zebrafish with abnormal phenotypes following a nicotine exposure between 12–30 hpf 
and 22–72 hpf. Dotted line denotes the boundaries of the spinal cord. The number of fish 
and hemisegments analyzed for each nicotine exposure paradigm is the same as in Table 1. 
Asterisk denotes statistical significance, p value < 0.05; double asterisks, p value < 0.001. 
Nicotine groups were compared against the control using a post hoc Holm-Sidak test. 
Cartoon is not drawn to scale.
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Figure 5. Three phenotypically distinct errors emerge on dorsal projecting SMN axons following 
embryonic nicotine exposure
A) Left, low magnification photomicrograph (zn5 immunoreactivity) reveals normal SMN 
axon trajectories (scale bar, 50 µm). Middle, diagram illustrates the normal trajectories of 
dorsal, ventral, and mediolateral motoneuron axons and the box outlines the region shown to 
the right. Right, high magnification photomicrograph reveals the normal trajectory path 
(arrowheads) of the dorsal projecting axon. Nicotine-induced phenotypes of dorsal 
projecting axons were categorized as “trajectory” (B), “split” (C) and “stall” (D) axonal 
errors. For each category, 4 representative example phenotypes are shown from different 
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nicotine exposed fish. B) “Trajectory” error refers to dorsal motoneuron axons that reach 
their dorsal most target but they drift (arrowheads) past their turning point and make sharp 
turns as they traject (open arrows). C) As the main nerve bundle of dorsal projecting SMN 
axons projects in the periphery, it splits (filled arrows) mainly into two different nerve 
fibers. D) Motor axons completely stall (dotted circle) as they exit the ventral root and fail to 
reach their dorsal most targets in the periphery. Arrowheads in D denote zn5-positive axons 
that have started to target dorsally after being stalled at the exit point. Scale bars, 20 µm.
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Figure 6. The nicotine-induced phenotypes of dorsal projecting SMN axons depend on the length 
of the exposure and nicotine concentration
A–C) Left, example cartoons depict one dorsal projecting SMN axons that has a normal 
projection and two abnormal phenotypes. Right, Quantification of the dorsal projecting 
SMN axons that have the corresponding abnormal phenotypes shown to the left (“trajectory” 
error, A; “split” axon error, B; “stall” axon error, C). Normal SMN axon phenotypes are 
shown in grey and abnormal phenotypes are shown in black. Dotted line denotes the 
boundaries of spinal cord. The number of fish and hemisegments analyzed for each nicotine 
exposure paradigm is the same as in Table 1. Dorsal is to the top and rostral is to the left. 
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Asterisk denotes statistical significance, p value < 0.05. Nicotine exposure groups were 
compared against the control using a post hoc Holm-Sidak (A) or Dunn’s test (B and C). 
Cartoons are not drawn to scale.
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Figure 7. anti-chrn2b labels a subset of primary motoneuron somata and axons in zebrafish 
embryos
A) Left, image of CaP motoneuron detected by anti-chrn2b in a 28-hpf embryo. The white 
open and white arrows indicate the soma and axon of the putative CaP motoneuron, 
respectively (same in B). B) Image of CaP motoneuron axon and soma as well as a dorsal 
projecting axon (yellow arrow) detected by anti-chrn2b in a 30 hpf embryo. C) Image of 32-
hpf embryo labeled with anti-chrn2b. Yellow arrow denotes the putative MiP motoneuron 
axon. White open arrow points to CaP motoneuron soma. Yellow circle highlights the 
presumptive soma of MiP motoneuron. D) Image from a 28-hpf embryo focusing on three 
ventral mytomes labeled with anti-chrn2b. E) Image from same fish in panel D now 
showing anti-chrn2b coupled with znp-1 labeling. F) Dual immunolabeling in a 31-hpf 
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embryo using anti-chrn2b and the zn5 antibody. The anti-chrn2b detected the ventral and 
dorsal projecting axons as shown from 1 body segment. The zn5 antibody labeled SMN 
somata and ventral projecting SMN axons. Note that the two antibodies detect two non-
overlapping axons ventrally and dorsally only the earlier born MiP motoneuron axon 
(yellow arrow) projects into the periphery. G) Image of a dorsal projecting motoneuron axon 
labeled with znp-1 in a 33-hpf embryo. H) Image is from the same segment shown in panel 
G. The MiP axon was detected by anti-chrn2b (yellow arrow). I) Merging of panels G and H 
reveals colocalization of znp-1 and anti-chrn2b signal at the level of the dorsal projecting 
axon. J) Image of a 24-hpf, pargmn2Et embryo. White arrows denote putative MiP 
motoneuron axons. K) Image of a 34-hpf pargmn2Et embryo. White arrow denotes MiP axon. 
L) Image is from the same segment shown in panel K where the embryo was labeled with 
anti-chrn2b. Yellow arrow denotes dorsal projecting axon. M) Merging of panels K and L 
reveals co-localization of GFP signal and anti-chrn2b axonal signal at the level of the MiP 
motoneuron axon. See Supplemental Table 1 for number of fish analyzed for each 
developmental time point. Scale bars; 10 µm.
Menelaou et al. Page 32













Figure 8. Simultaneous examination of nicotine-induced effects onto primary and secondary 
motoneuron axons
A–C) Representative photomicrographs from a 72-hpf control larva labeled with the zn5 
antibody and anti-chrn2b. Photomicrographs from 3 different 72-hpf larvae labeled with the 
zn5 antibody and anti-chrn2b and exposed to either 30µM nicotine from 12–30 hpf (D–F), 
1µM nicotine from 22–72 hpf (G–I) or 30µM nicotine from 22–72 hpf (J–L). Yellow arrows 
in each exposure example denote SMN axons that extended too far caudally before turning 
dorsally. See Supplemental Table 1 for number of fish analyzed for each nicotine exposure 
paradigm. Scale bars; 20 µm.
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Figure 9. The nicotine-induced “stall” and “duplication” errors are specific to SMN axons
A–C) Photomicrographs of a 72-hpf larva exposed to 30µM nicotine from 22–72 hpf. The 
zn5-positive SMN dorsal projecting axons (yellow arrows in A) have not extended into the 
periphery and appear to have stalled. B–C) Anti-chrn2b antibody detects MiP motoneuron 
axons in the periphery whereas zn5-positive SMN axons have not extended into the 
periphery. D) Image of a 72-hpf larva exposed to 30µM nicotine from 22–72 hpf. There is a 
duplicated SMN nerve root shown by the yellow arrow. E) Photomicrograph of the fish 
shown in D labeled with anti-chrn2b. The anti-chrn2b-positive dorsal and ventral projecting 
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axons extended out into the periphery in these 3 consecutive segments. There was no ventral 
nerve root duplication that matched the zn5-positive one in panel D (yellow arrow). See 
Supplemental Table 1 for number of fish analyzed for each nicotine exposure paradigm. 
Scale bars; 20 µm.
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Figure 10. Differential effects along the motoneuron axon path following nicotine exposures
A–C) Photomicrographs of a 72-hpf larva labeled with zn5 and anti-chrn2b capture 
motoneuron axon extension within 1 segment just below spinal cord (ventral edge of spinal 
cord indicated by white arrowheads). This larva was exposed to 30µM from 22–72 hpf. Note 
that the zn5-positive axon appears stalled at this magnification whereas the anti-chrn2b-
positive axon (white arrow in panel B) takes a dorsal trajectory. Yellow arrow in A points to 
a weak zn5 signal; likely a few axons which have migrated dorsally. The asterisk in A 
provides a reference point of the magnified area in D–F. D–F) The images in A–C shown at 
higher magnification. Zn5-positive axons appear to migrate to the periphery using the anti-
chrn2b - positive axon as a guide. Conventions are the same as in A–C. G–I) 
Photomicrographs of a 72-hpf larva labeled with zn5 and anti-chrn2b. This larva was 
exposed to 30µM from 22–72 hpf. Zn5-positive axons appear to use the anti-chrn2b-positive 
axon as a guide when navigating below spinal cord (marked by asterisks). Once in the distal 
dorsal periphery, the zn5-positive axons exhibit pathfinding errors (yellow arrow) whereas 
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the anti-chrn2b-positive axon targeted the periphery using a slightly different dorsal path 
(white arrow). The zebrafish larva presented under panels A–F was presented earlier in Fig. 
2Ei. See Supplemental Table 1 for number of fish analyzed for each nicotine exposure 
paradigm. Scale bars; 10 µm in C and F, 20 µm in I.
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